NEW YORK, June 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the "Class Period"), of the important July 14, 2025 lead...
Read More Details
Finally We wish PressBee provided you with enough information of ( IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit )
Also on site :
- Woman arrested for gathering intel near Crimean Bridge – FSB
- Russia and UN official discuss steps to end Sudan conflict
- Pepperidge Farm Launches 'Awesome' New Goldfish Flavor, Revives a Favorite